Berkshire Hathaway Inc. Common Stock Stock (NYSE: BRK/A)

Berkshire Hathaway Inc. Common Stock (NYSE:BRK/A) Stock, Quote.Headers.trade-ideas

Berkshire Hathaway Inc. Common Stock

Entertainment

Education

General

BRK-A

BRK-B

Over the years, Warren Buffett has become known as one of the most legendary investors of all time thanks to his acquisitions of many companies, stakes in public companies, while having an eye for value.

If You Invested $1,000 In Berkshire Hathaway Stock When Warren Buffett Appeared In The Entourage Movie, Here&#39;s How Much You&#39;d Have Today

News

Small Cap

Management

AMZN

CVNA

EBAY

ORCL

TSLA

VSCO

The Forbes 400 list of the richest people in America is out and has several people leaving the list and newcomers such as Michael Jordan making their first appearance.

Here&#39;s The Richest Person In Each State With A Forbes 400 Member: Elon Musk, Jeff Bezos Make List; Bill Gates, Mark Zuckerberg Beaten By Others

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Exclusives

Markets

Interview

$BTC

AAPL

Morgan Creek Capital Management CEO and founder Mark Yusko is a firm believer in the future of Bitcoin (CRYPTO: BTC) and has choice words for crypto 

EXCLUSIVE: Yusko Calls Out Warren Buffett, &#39;The Reason Warren Wants To P--- On Bitcoin Is...&#39;

Berkshire Hathaway Inc

Committed to exploring new markets, NANO Nuclear Energy is assessing the potential for deploying its advanced technologies in space applications &nbsp;
New York, N.Y., Sept. 23, 2024 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>)&nbsp;("NANO Nuclear" or "the Company"),&nbsp;a leading advanced nuclear energy and technology company focused on developing portable, clean energy solutions, today announced the launch of a new subsidiary, NANO Nuclear Space Inc. (NNS), to explore the potential commercial applications of the Company's developing micronuclear reactor technology in space.
NNS will utilize NANO Nuclear's world class scientific and engineering teams to examine the adaptation of NANO Nuclear technologies to contribute towards humanity's drive to expand beyond low earth orbit. NNS will focus on optimizing&nbsp;"ZEUS", a solid core battery reactor, and "ODIN", a low-pressure coolant reactor, for applications such as power systems for extraterrestrial projects and human sustaining environments, and potentially propulsion technology for long haul space missions. NNS' initial focus will be on cis-lunar applications, referring to uses in the space region extending from Earth to the area surrounding the Moon's surface.

NANO Nuclear Energy Forms NANO Nuclear Space To Explore Use Of Advanced Portable Microreactors In Space Applications

Piper Sandler analyst Edward Tenthoff reiterates Dyne Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) with a Overweight and maintains $53 price target.

Price Target

Reiteration

Analyst Ratings

Piper Sandler Reiterates Overweight on Dyne Therapeutics, Maintains $53 Price Target

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPCR#NASDAQ">GPCR</a>) with a Overweight and maintains $65 price target.

GPCR

Cantor Fitzgerald Reiterates Overweight on Structure Therapeutics, Maintains $65 Price Target

TPCS

TechPrecision Appoints Richard Roomberg As CFO

Guidance

BRLS

Borealis Foods Introduces Woodles Into U.S. School Lunch Programs;  Expects Revenue And Gross Profit Contribution In H2 2024 And Beyond

FIVN

VRNT

Verint And Five9 Expand Partnership To Deliver AI-Driven Customer Experiences With New Cloud-To-Cloud Platform Integration

Contracts

SPCB

SuperCom Receives Three-Year Contract With A European Government To Deploy Its PureSecurity Domestic Violence Monitoring Solution; Financial Terms Not Disclosed

Cantor Fitzgerald analyst Andres Sheppard reiterates Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Neutral and maintains $245 price target.

Cantor Fitzgerald Reiterates Neutral on Tesla, Maintains $245 Price Target

SABR

Virgin Australia Partners With Sabre To Modernize Retailing Capabilities Using AI-Driven SabreMosaic Platform, Becoming Flagship Customer For Full Technology Adoption

In the first half of 2024, Wearable Devices continued recognizing revenue from the sale of Mudra Band for Apple Watch, the Company's flagship B2C product, which began shipping towards the end of 2023. Revenues for the six months ended June 30, 2024 were $394 thousand, increasing from approximately $12 thousand compared to the six months ended June 30, 2023. Net loss increased to $4.2 million, or $(0.21) per basic and diluted share, in the six months ended June 30, 2024, compared to net loss of $3.9 million, or $(0.26) per basic and diluted share, for the six months ended June 30, 2023, primarily related to an increase in the Company's operating expenses associated with its continued efforts to scale its business activity.

Earnings

WLDS

Wearable Devices H1 2024 EPS $(0.21) Up From $(0.26) YoY; Revenue $394K Up From $12K YoY

BKYI

BIO-key Announces Expansion Of Identity Management Solutions For British Columbia, Adding 10,000 Users To Existing WEB-key Deployment Integrated With Broadcom's SiteMinder

EF Hutton analyst Jason Kolbert initiates coverage on Imunon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) with a Buy rating and announces Price Target of $29.

Initiation

IMNN

EF Hutton Initiates Coverage On Imunon with Buy Rating, Announces Price Target of $29

Biotech

VTGN

Vistagen Initiates PALISADE-4 Phase 3 Study Of Fasedienol For Acute Treatment Of Social Anxiety Disorder

AMPX

Amprius Receives Two Contracts To Supply 40 ah High-Performance Cells For Light Electric Vehicle Applications; Contracts' Total Exceeds $20M

Kazia Therapeutics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>), an oncology-focused drug development company, is pleased to announce the presentation of data highlighting promising clinical activity of EVT801 in high grade serous (HGS) Ovarian Cancer at the 15th Biennial Ovarian Cancer Research Symposium, co-presented by American Association of Cancer Research (AACR) and the Rivkin Center for Ovarian Cancer Research on Saturday, September 21, 2024 in Seattle Washington.
Dr. John Friend, CEO Kazia Therapeutics presented preliminary data from a Phase 1 first-in-human clinical trial evaluating the safety and tolerability of EVT801, a highly selective small molecule VEGFR3 inhibitor targeting tumour angiogenesis. The Phase 1 study met its primary objectives, with the maximal tolerated dose identified at 500mg twice a day (BID). The Phase 1 study also identified the recommended Phase 2 dose starting at 400mg BID. It was observed that EVT801 was tolerated across all doses, with the majority of toxicities being mild to moderate and transient in nature.
Key points of the presentation included:
<ul>
<li>A total of 26 patients were treated across 6 dosing cohorts ranging from 50mg once daily (QD) to 500mg twice daily (BID)</li>
<li>Patients with eleven different cancer types (ex. colon, renal cell, pancreatic) were enrolled in the study, with heavily pretreated advanced ovarian cancer being the most prevalent indication (11 patients)</li>
<li>Biomarkers have shown strong VEGFR3 expression in multiple indications, including ovarian cancer</li>
<li>Encouraging clinical activity in High Grade Serous ovarian cancer patients with forty-six percent (46%) having stable disease or for at least three cycles, including two patients who received 9 cycles</li>
<li>One patient had a partial response (-39% decrease) after 2 cycles of EVT801 therapy</li>
</ul>

KZIA

Kazia Therapeutics Announces Presentation Of EVT801 Clinical Data At 15th Biennial Ovarian Cancer Research Symposium

Piper Sandler analyst Yasmeen Rahimi reiterates NewAmsterdam Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMS#NASDAQ">NAMS</a>) with a Overweight and maintains $37 price target.

NAMS

Piper Sandler Reiterates Overweight on NewAmsterdam Pharma, Maintains $37 Price Target

DA Davidson analyst Gil Luria downgrades Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) from Buy to Neutral and announces $475 price target.

Downgrades

MSFT

DA Davidson Downgrades Microsoft to Neutral, Announces $475 Price Target

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk on Saturday said that buses will not be needed when the EV giant ultimately achieves autonomous driving capability with its full self-driving (FSD) driver assistance software. 
What Happened: If electric buses need to be equipped with diesel generators for heat when the temperature drops, it means that their battery packs are too small, Musk said on social media platform X. The CEO was responding to a user by the name of Peter Imanuelsen who alleged that several buses in Norway had to be equipped with diesel generators to warm the cabin during the last winter.
&#8220;&#8230;busses will not be needed when Tesla rolls out unsupervised full self-driving, as they will take people point to point for a similar cost to a bus ticket,&#8221; the CEO added, implying that the cost of availing Tesla robotaxis would be low once they enter operations. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Then the battery packs of the busses are too small. Teslas can operate well even above the Arctic Circle. Also, busses will not be needed when Tesla rolls out unsupervised full self-driving, as they will take people point to point for a similar cost to a bus ticket.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1837506412357824960?ref_src=twsrc%5Etfw">September 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Musk is now aiming to make Tesla vehicles capable of autonomous driving with new iterations of its FSD. The software currently requires active driver supervision but will enable autonomous driving in the future, according to the CEO. The company is also looking to unveil its <a href="https://www.benzinga.com/news/24/07/39929718/tesla-robotaxi-unveiling-set-for-oct-10-here-are-the-updates-from-company-ceo-elon-musk-on-its-upcom">dedicated robotaxi offering in October.</a> 
Musk expects his company's robotaxi fleet to function like a&nbsp;<a href="https://www.benzinga.com/news/24/04/38396288/teslas-robotaxi-to-be-called-cybercab-elon-musk-says-self-driving-fleet-will-be-like-combination-of" target="_blank" rel="noreferrer noopener">combination of Airbnb and Uber</a>. While a certain portion of the fleet will be owned by Tesla, individual Tesla customers can also add or subtract their vehicles to the robotaxi fleet at will for additional income. As for riders, they can summon a car using the Tesla App, Musk said.
Earlier this month, Tesla said in a post on X that it will focus on improving FSD throughout this year in the U.S. and deploying the software on its latest vehicle offering – the Cybertruck- before rolling it out in Europe and China in the first quarter of 2025.
During Tesla&#8217;s second-quarter earnings call in July, Musk said that unsupervised driving on a Tesla could be possible <a href="https://www.benzinga.com/news/24/09/40808924/tesla-robotaxi-event-to-be-held-in-los-angeles-on-1010-says-senior-company-exec-existing-shareholder">by late 2024 or in 2025.</a> However, the CEO is known for overestimating the capabilities of his company&#8217;s different offerings and for providing changing timelines. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40968441/russian-presidents-ally-ramzan-kadyrov-says-elon-musk-remotely-turned-off-his-cybertruck-in-russia">Russian President&#8217;s Ally Ramzan Kadyrov Says Elon Musk Remotely Turned Off His Cybertruck In Russia</a></li>
</ul>
Image via Shutterstock

Equities

Tech

Elon Musk Says Buses Won't Be Needed Once Tesla Robotaxis Start Operating: 'Will Take People Point To Point For A Similar Cost'

Macro Economic Events

Econ #s

Economics

USA Chicago Fed National Activity For August 0.12 Vs -0.20 Est.; -0.42 Prior (Revised From -0.34)

Telos Expands Enrollment And Renewal Options By Opening New Locations

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Berkshire Hathaway Inc. Common Stock (NYSE:<a href="https://investorplace.com/stock-quotes/brk-a-stock-quote/">BRK/A</a>) just reported results for the first quarter of 2024.<ul><li>Berkshire Hathaway Inc. Common Stock reported earnings per share of $7,796.47. This was above the analyst estimate for EPS of $6,824.88.</li><li>The company reported revenue of $89.87 billion.</li><li>This was 3.25% better than the analyst estimate for revenue of $87.04 billion.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/brk-a-stock-earnings-berkshire-hathaway-inc-common-stock-for-q1-of-2024/">BRK/A Stock Earnings: Berkshire Hathaway Inc. Common Stock Beats EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BRK/A Stock Earnings: Berkshire Hathaway Inc. Common Stock Beats EPS, Beats Revenue for Q1 2024

BRK/A

Enact Holdings

Affirm Holdings, Inc. - Class A Common Stock

Affirm Holdings

Berkshire Hathaway Inc. New Common Stock

Mr. Cooper Gr

Corpay

Corebridge Financial

Equitable Hldgs

Essent Group

Fiserv

Fidelity National Information Services, Inc. Common Stock

Fidelity National Info

Shift4 Payments, Inc. Class A Common Stock

Shift4 Payments

Global Payments

ORIX

Jack Henry & Associates, Inc. - Common Stock

Jack Henry & Associates

Jackson Financial Inc. Class A Common Stock

Jackson Finl

Mastercard

MGIC Investment

PennyMac Financial Services, Inc. Common Stock

PennyMac Financial Servs

PayPal Holdings

Radian Group

Block

Toast

Visa

Voya Financial

Keefe, Bruyette & Woods

Berkshire Hathaway

Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group. Berkshire has used the excess cash thrown off from these and its other operations over the years to acquire Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy (utilities and energy distributors), and the companies that make up its manufacturing, service, and retailing operations (which include five of Berkshire's largest noninsurance pretax earnings generators: Precision Castparts, Lubrizol, Clayton Homes, Marmon, and IMC/ISCAR). The conglomerate is unique in that it is run on a completely decentralized basis.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Berkshire Hathaway Inc. Common Stock

Berkshire Hathaway Inc. Common Stock (BRK/A) Forecast

Berkshire Hathaway Inc. Common Stock (NYSE:BRK/A) Stock, Quote.Headers.trade-ideas